| For Practicing Oncologists |
  See all
 | Articles: General Oncology
|
|
Receive daily email updates on: General Oncology
|
 | | Sponsor |
Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer
British Journal of Cancer, 07/08/08
The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: A prospective survey
Digestive and Liver Diseases, 07/08/08
Columnar cell lesions, mammographic density and breast cancer risk
Breast Cancer Research and Treatment, 07/08/08
Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer.
Anti-Cancer Drugs, 07/08/08
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck
Anti-Cancer Drugs, 07/08/08
Phase I/II study of a 3 weekly oral taxane (DJ-927) in patients with recurrent, advanced non-small cell lung cancer
Journal of Thoracic Oncology, 07/08/08
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration
Annals of Hematology, 07/08/08
Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx
Clinical Cancer Research, 07/08/08
DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma
British Journal of Cancer, 07/08/08
Managing premedications and the risk for reactions to infusional monoclonal antibody therapy
The Oncologist, 07/08/08
|
|
Receive daily email updates on: General Oncology
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
 |
| Sponsor |
|
